


Psychedelic Action Task Force Revenue
Mental Health Care • • 1-10 Employees
Psychedelic Action Task Force revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Mental Health Care industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Psychedelic Action Task Force
Alex Adams
Co-founder & Chair
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 621112 |
| Keywords | Psychiatry, Mental Health, Neuropsychopharmacology, Psychedelic Research, Psychedelic Healthcare |
| Founded | 2024 |
| Employees | 1-10 |
About Psychedelic Action Task Force
We believe that clinical adoption of psychedelic therapies represents an opportunity to reduce human suffering on an unprecedented scale. The Psychedelic Action Task Force is a clinician- and scientist-led coalition working to redress the UK mental health crisis and provide solutions to its severe social and economic repercussions, namely, through the democratisation of access to psychedelic treatments in respect of which there is sufficient evidence of both safety and efficacy. Founded by Prof. David Nutt and Alex Adams, Psychedelic Action will be advocating for evidence-based drug policy reform, conducting a revaluation of current clinical paradigms, and facilitating the integration of psychedelic therapy into the UK healthcare system, including the training of clinicians and therapists. Executive Committee: Prof. David Nutt, Alex Adams, Dr. Leyla Hussein OBE, Mabel Evans
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Psychedelic Action Task Force has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Psychedelic Action Task Force has never raised funding before.
Frequently asked questions
4.8
40,000 users



